Francisca Ferreira
Katholieke Universiteit Leuven
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Francisca Ferreira.
International Journal of Chronic Obstructive Pulmonary Disease | 2017
Bita Hajian; Jan De Backer; Claire Sneyers; Francisca Ferreira; Katherine C Barboza; Glenn Leenmans; Wim Vos; Wilfried De Backer
Introduction Patients with severe COPD often develop chronic hypercapnic respiratory failure. Their prognosis worsens and they are more likely to develop exacerbations. This has major influence on the health-related quality of life. Currently, there is no information about the success of long-term noninvasive ventilation (NIV) among patients who receive NIV in acute settings. Also, little is known about the pathophysiological mechanism of NIV. Methods Ten Global Initiative for Obstructive Lung Disease stage III and IV COPD patients with respiratory failure who were hospitalized following acute exacerbation were treated with NIV using a Synchrony BiPAP device for 6 months. Arterial blood gases and lung function parameters were measured. Low-dose computed tomography of the thorax was performed and used for segmentation. Further analyses provided lobe volume, airway volume, and airway resistance, giving an overall functional description of the separate airways and lobes. Ventilation perfusion (VQ) was calculated. Patient-reported outcomes were evaluated. Results PaCO2 significantly improved from 50.03 mmHg at baseline to 44.75 mmHg after 1 month and 43.37 mmHg after 6 months (P=0.006). Subjects showed improvement in the 6-minute walk tests (6MWTs) by an average of 51 m (from 332 m at baseline to 359 m at 1 month and 383 m at 6 months). Patients demonstrated improvement in self-reported anxiety (P=0.018). The improvement in image-based VQ was positively associated with the 6MWT and the anxiety domain of the Severe Respiratory Insufficiency Questionnaire. Conclusion Though previous studies of long-term NIV have shown conflicting results, this study demonstrates that patients can benefit from long-term NIV treatment, resulting in improved VQ, gas exchange, and exercise tolerance.
Physiological Reports | 2016
William R. Henderson; Yannick Molgat-Seon; W. Vos; Rachel Lipson; Francisca Ferreira; Miranda Kirby; Cedric Van Holsbeke; Paolo B. Dominelli; Donald E. Griesdale; Mypinder Sekhon; Harvey O. Coxson; John R. Mayo; A. William Sheel
Heterogeneity in regional end expiratory lung volume (EELV) may lead to variations in regional strain (ε). High ε levels have been associated with ventilator‐associated lung injury (VALI). While both whole lung and regional EELV may be affected by changes in positive end‐expiratory pressure (PEEP), regional variations are not revealed by conventional respiratory system measurements. Differential rates of deflation of adjacent lung units due to regional variation in expiratory time constants (τE) may create localized regions of ε that are significantly greater than implied by whole lung measures. We used functional respiratory imaging (FRI) in an ex vivo porcine lung model to: (i) demonstrate that computed tomography (CT)‐based imaging studies can be used to assess global and regional values of ε and τE and, (ii) demonstrate that the manipulation of PEEP will cause measurable changes in total and regional ε and τE values. Our study provides three insights into lung mechanics. First, image‐based measurements reveal egional variation that cannot be detected by traditional methods such as spirometry. Second, the manipulation of PEEP causes global and regional changes in R, E, ε and τE values. Finally, regional ε and τE were correlated in several lobes, suggesting the possibility that regional τE could be used as a surrogate marker for regional ε.
International Journal of Chronic Obstructive Pulmonary Disease | 2016
Bita Hajian; Jan De Backer; Wim Vos; Cedric Van Holsbeke; Francisca Ferreira; Deborah A Quinn; Annemie Hufkens; Rita Claes; Wilfried De Backer
Introduction Severe chronic obstructive pulmonary disease (COPD) is often associated with secondary pulmonary hypertension (PH), which worsens prognosis. PH can be lowered by oxygen, but also by inhaled nitric oxide (NO), which has the potential to improve the health status of these patients. NO is an important mediator in vascular reactions in the pulmonary circulation. Oral compounds can act through NO-mediated pathways, but delivering pulsed inhaled NO (iNO) directly to the airways and pulmonary vasculature could equally benefit patients. Therefore, a proof-of-concept study was performed to quantify pulmonary blood vessel caliber changes after iNO administration using computed tomography (CT)-based functional respiratory imaging (FRI). Methods Six patients with secondary PH due to COPD received “pulsed” iNO in combination with oxygen for 20 minutes via a nasal cannula. Patients underwent a high-resolution CT scan with contrast before and after iNO. Using FRI, changes in volumes of blood vessels and associated lobes were quantified. Oxygen saturation and blood pressure were monitored and patients were asked about their subjective feelings. Results Pulmonary blood vessel volume increased by 7.06%±5.37% after iNO. A strong correlation (Ω20=0.32, P=0.002) was obtained between ventilation and observed vasodilation, suggesting that using the pulsed system, iNO is directed toward the ventilated zones, which consequently experience more vasodilation. Patients did not develop oxygen desaturation, remained normotensive, and perceived an improvement in their dyspnea sensation. Conclusion Inhalation of pulsed NO with oxygen causes vasodilation in the pulmonary circulation of COPD patients, mainly in the well-ventilated areas. A high degree of heterogeneity was found in the level of vasodilation. Patients tend to feel better after the treatment. Chronic use trials are warranted.
Multidisciplinary Respiratory Medicine | 2017
Francesca Ruscitti; Francesca Ravanetti; Jeroen Essers; Yanto Ridwan; Sasha Belenkov; Wim Vos; Francisca Ferreira; Alex KleinJan; Paula M. van Heijningen; Cedric Van Holsbeke; Antonio Cacchioli; Gino Villetti; Franco Fabio Stellari
European Respiratory Journal | 2017
Eduardo J. Mortani Barbosa; Francisca Ferreira; Wim Vos; Cedric Van Holsbeke; Wilfried De Backer; Jan De Backer; James Lee
Journal of Heart and Lung Transplantation | 2016
Eduardo J. Mortani Barbosa; Francisca Ferreira; W. Vos; C. Van Holsbeke; L. Nuyttens; W. De Backer; J. De Baker; Jimmy Lee
European Respiratory Journal | 2016
Eduardo J. Mortani Barbosa; Francisca Ferreira; Wim Vos; Cedric Van Holsbeke; Lieven Nuyttens; Wilfried De Backer; Jan De Backer; Jimmy Lee
European Respiratory Journal | 2015
Francisca Ferreira; Veronique Verplancke; Wim Vos; Cedric Van Holsbeke; Jan De Backer; Wilfried De Backer; Peter Van Hal
European Respiratory Journal | 2015
Bita Hajian; Francisca Ferreira; Wim Vos; Jan De Backer; Cedric Van Holsbeke; Douglas Greene; Reinilde Heyrman; Wilfried De Backer
European Respiratory Journal | 2015
Francisca Ferreira; William R. Henderson; Cedric Van Holsbeke; Wim Vos; Jan De Backer; Yannick Molgat-Seon; Miranda Kirby; Paolo B. Dominelli; Donald E. Griesdale; Mypinder S. Sekhon; Harvey O. Coxson; John R. Mayo; William Sheel